Isoflavones from soya foods are more bioavailable in children than adults

British Journal of Nutrition

Volumn 98, Issue 5, 2007, Pages 998-1005

  Halm, Brunhild M ^a   Ashburn, Leslie A ^a   Franke, Adrian A ^a  

^a UNIVERSITY OF HAWAII CANCER CENTER   (United States)

Author keywords

Bioavailability; Children; Isoflavones; Soya

Indexed keywords

DAIDZEIN; GENISTEIN; GLYCITEIN; ISOFLAVONE DERIVATIVE; ISOFLAVONOID;

ACCURACY; ADOLESCENT; ADULT; AGE; ARTICLE; BIOAVAILABILITY; BODY WEIGHT; CHILD; CHILD NUTRITION; CONTROLLED STUDY; FEMALE; FOOD INTAKE; HUMAN; HUMAN EXPERIMENT; MALE; NON INVASIVE MEASUREMENT; NORMAL HUMAN; NUTRITIONAL ASSESSMENT; SOYBEAN; STUDENT T TEST; UNITED STATES; URINALYSIS; URINARY EXCRETION;

ADOLESCENT; ADULT; AGING; BIOLOGICAL AVAILABILITY; BODY WEIGHT; CHILD; CHILD NUTRITION PHYSIOLOGY; CHILD, PRESCHOOL; FEMALE; GENISTEIN; HUMANS; ISOFLAVONES; MALE; SOY FOODS;

EID: 35148862578     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114507771866     Document Type: Article

References (54)

1. Messina M, Persky V, Setchell KDR & Barnes S (1994) Soy intake and cancer risk: A review of in vitro and in vivo data. Nutr Cancer 21, 113-131.
2. Barnes S, Grubbs C, Setchell KDR & Carlson J (1990) Soy-beans inhibit mammary tumors in models of breast cancer. In Mutagens and Carcinogens in the Diet, pp. 239-254 [W Pariza, U Aeschbacher, JS Felton and S Sato, editors]. New York: Wiley Liss.
3. Lamartiniere CA, Moore J, Holland M & Barnes S (1995) Neonatal genistein chemoprevents mammary cancer. Proc Soc Exp Bio Med 208, 120-123.
4. Murrill WB, Brown NM, Zhang J-X, Manzolillo PA, Barnes S & Lamartiniere CA (1996) Prepubertal genistein exposure suppresses mammary cancer and enhances gland differentiation in rats. Carcinogenesis 17, 1451-1457.
5. Pollard M & Luckert PH (1997) Influence of isoflavones in soy protein isolates on development of induced prostate-related cancers in L-W rats. Nutr Cancer 28, 41-45.
6. Zhang J-X, Hallmans G, Landstrom M, Bergh A, Damber JE, Aman P & Adlercreutz H (1997) Soy and rye diets inhibit the development of Dunning R3327 prostatic adenecarcinoma in rats. Cancer Lett 114 313-314.
7. Uckun FM, Evans WE, Forsyth CJ, Waddick KG, Ahlgren LT, Chelstrom LM, Burkhardt A, Bolen J & Myers DE (1995) Biotherapy of B-cell precursor leukemia by targeting genistein to CD19- associated tyrosine kinases. Science 267, 886-891.
8. Umphress ST, Murphy SP, Franke AA, Custer LJ & Blitz CL (2005) Isoflavone content of foods with soy additives. J Food Comp Anal 18, 533-550.
9. Franke AA, Custer LJ, Cerna CM & Narala K (1995) Rapid HPLC analysis of dietary phytoestrogens from legumes and from human urine. Proc Soc Exp Biol Med 208, 18-26.
10. Adlercreutz H & Mazur W (1997) Phyto-oestrogens and Western diseases. Ann Med 29, 95-120.
11. Horn-Ross PL, Lee M, John EM & Koo J (2000) Sources of phytoestrogen exposure among non-Asian women in California, USA. Cancer Causes Control 11, 299-302.
12. Yan L & Spitznagel E (2004) A meta-analysis of soyfoods and risk of breast cancer in women. Int J Cancer Prev 1, 281-293.
13. Shu XO, Jin F, Dai Q, Wen W, Potter JD, Kushi LH, Ruan Z, Gao ZT & Wheng W (2001) Soyfood intake during adolescence and subsequent risk of breast cancer among Chinese women. Cancer Epidemiol Biomarkers Prev 10 483-488.
14. Wu AH, Wan P, Hankin J, Tseng CC, Yu MC & Pike MC (2002) Adolescent and adult soy intake and risk of breast cancer in Asian-Americans. Carcinogenesis 23, 1491-1496.
15. Franke AA, Custer LJ, Wang W & Shi SJ (1998) HPLC analysis of isoflavonoids and other phenolic agents from foods and from human fluids. Proc Soc Exp Biol Med 217, 263-273.
16. Franke AA, Custer LJ & Hundahl SA (2004) Determinants for urinary and plasma isoflavones in humans after soy intake. Nutr Cancer 50 141-154.
17. Setchell KD, Brown NM, Desai PB, Zimmer-Nechimias L, Wolfe B, Jakate AS, Creutzinger V & Heubi JE (2003) Bioavailability, disposition, and dose-response effects of soy isoflavones when consumed by healthy women at physiologically typical dietary intakes. J Nutr 133, 1027-1035.
18. Zubik L & Meydani M (2003) Bioavailability of soybean isoflavones from aglycone and glucoside forms in American women. Am J Clin Nutr 77, 1459-1465.
19. Richelle M, Pridmore-Merten S, Bodenstab S, Enslen M & Offord EA (2002) Hydrolysis of isoflavone glycosides to aglycones by β-glycosidase does not alter plasma and urine isoflavone pharmacokinetics in postmenopausal women. J Nutr 132, 2587-2592.
20. Hollman PCH (2004) Absorption, bioavailability, and metabolism of flavonoids. Pharm Biol 42, 74-83.
21. Seow A, Shi C-Y, Franke AA, Hankin J, Lee H-P & Yu MC (1998) Isoflavonoid levels in spot urine are associated with frequency of dietary soy intake in a population-based sample of middle-aged and older Chinese in Singapore. Cancer Epidemiol Biomarkers Prev 7, 135-140.
22. Chen Z, Zheng W, Custer LJ, Dai Q, Shu X-O, Jin F & Franke AA (1999) Usual dietary consumption of soy foods and its correlation with the excretion rate of isoflavonoid in overnight urine samples among Chinese women in Shanghai. Nutr Cancer 33, 82-87.
23. Atkinson C, Skor HE, Fitzgibbons ED, Scholes D, Chen C, Wahala K, Schwartz SM & Lampe JW (2002) Overnight urinary isoflavone excretion in a population of women living in the United States, and its relationship to isoflavone intake. Cancer Epidemiol Biomarkers Prev 11, 253-260.
24. Grace PB, Taylor JI, Low YL, et al. (2004) Phytoestrogen concentrations in serum and spot urine as biomarkers for dietary phytoestrogen intake and their relation to breast cancer risk in European Prospective Investigation of Cancer and Nutrition-Norfolk. Cancer Epidemiol Biomarkers Prev 13, 698-708.
25. Wu AH, Yu MC, Tseng CC, Twaddle NC & Doerge DR (2004) Plasma isoflavone levels versus self-reported soy isoflavone levels in Asian-American women in Los Angeles County. Carcinogenesis 25, 77-81.
26. Fanti P, Stephenson TJ, Kaariainen IM, Rezkalla B, Tsukamoto Y, Morishita T, Nomura M, Kitiyakara C, Custer LJ & Franke AA (2003) Soy food intake and serum levels of soy isoflavones in Japanese, Thai and North American end-stage renal failure patients on chronic hemodialyis therapy. Nephrol Dial Transplant 18, 1862-1868.
27. Ritchie MR, Morton MS, Deighton N, Blake A & Cummings JH (2004) Plasma and urinary phyto-oestrogens as biomarkers of intake: Validation by duplicate diet analysis. Br J Nutr 91, 447-457.
28. Franke AA, Halm BM, Custer LJ, Tatsumura Y & Hebshi S (2006) Isoflavones in breastfed infants after mothers consume soy. Am J Clin Nutr 84, 406-413.
29. Franke AA & Custer LJ (1994) High-performance liquid chromatography assay of isoflavonoids and coumestrol from human urine. J Chromatogr B 662, 47-60.
30. Hoey L, Rowland IR, Lloyd AS, Clarke DB & Wiseman H (2004) Influence of soya-based infant formula consumption on isoflavone and gut microflora metabolite concentrations in urine and on faecal micreflora composition and metabolic activity in infants and children. Br J Nutr 91 607-616.
31. Setchell KDR, Zimmer-Nechemias L, Cai J & Heubi JE (1997) Exposure of infants to phyto-oestrogens from soy-based infant formula. Lancet 350, 23-27.
32. Franke AA, Hankin JH, Yu MC, Maskarinec G, Low SH & Custer LJ (1999) Isoflavone levels in soy foods consumed by multiethnic populations in Singapore and Hawaii. J Agric Food Chem 47, 977-986.
33. Tsukamoto C, Shimada S, Igita K, Kudou S, Kokubun M, Okubo K & Kitamura A (1995) Factors affecting isoflavone content in soybean seeds: Changes in isoflavones, saponins, and composition of fatty acids at different temperatures during seed development. J Agric Food Chem 43, 1184-1192.
34. Blair RM, Appt SE, Franke AA & Clarkson TB (2003) Treatment with antibiotics reduces-plasma equol concentration in cynomolgus monkeys (Macaca fascicularis). J Nutr 133, 2262-2267.
35. Franke AA, Custer LJ, Wilkens LR, Le Marchand L, Nomura AN, Goodman MT & Kolonel LN (2002) Liquid chromatographic analysis of dietary phytoestrogens from human urine and blood. J Chromatogr B Analyt Technol Biomed Life Sci 777, 43-57.
36. Cline JM, Franke AA, Register TC, Golden DL & Adams MR (2004) Effects of dietary isoflavone aglycones on the reproductive tract of male and female mice. Toxicol Pathol 32, 91-99.
37. Adams MR, Golden DL, Franke AA, Potter SM, Smith HS & Anthony MS (2004) Dietary soy β-conglycinin (7S globulin) inhibits atherosclerosis in mice. J Nutr 134, 511-516.
38. Franke AA, Halm BM, Custer LJ, Tatsumura Y & Hebshi S (2006) Isoflavones in breastfed infants after mothers consume soy. Am J Clin Nutr 84, 406-413.
39. Fomon SJ (1993) Nutrition of Normal Infants. St Louis: Mosby.
40. Remer T, Neubert A & Maser-Gluth C (2002) Anthropometry-based reference values for 24-hr urinary creatinine excretion during growth and their use in endocrine and nutritional research. Am J Clin Nutr 75 561-569.
41. Kesteloot H & Joossens JV (1996) On the determinants of the creatinine clearance: A population study. J Hum Hypertens 10, 245-249.
42. Barr DB, Wilder LC, Caudill SP, Gonzalez AJ, Needham LL & Pirkle JL (2005) Urinary creatinine concentrations in the U.S. population: implications for urinary biologic monitoring measurements. Environ Health Perspect 113, 192-200.
43. Kampmann J, Siersbaek-Nielsen K, Kristensen M & Hansen JM (1974) Rapid evaluation of creatinine clearance. Acta Med Scand 196, 517-520.
44. Maskarinec G, Singh S, Meng L & Franke AA (1998) Dietary soy intake and urinary isoflavone excretion among women from a multiethnic population. Cancer Epidemiol Biomarkers Prev 7, 613-619.
45. Maskarinec G, Morimoto Y, Novotny R, Nordt FJ, Stanczyk FZ & Franke AA (2005) Urinary sex steroid excretion levels during a soy intervention among young girls: A pilot study. Nutr Cancer 52, 22-28.
46. Messina M, Nagata C & Wu AH (2006) Estimated Asian adult soy protein and isoflavone intakes. Nutr Cancer 55, 1-12.
47. Nagata C, Iwasa S, Shiraki M, Ueno T, Uchiyama S, Urata K, Sahashi Y & Shimizu H (2006) Associations among maternal soy intake, isoflavone levels in urine and blood samples, and maternal and umbilical hormone concentrations (Japan). Cancer Causes Control 17, 1107-1113.
48. Yan L & Spitznagel EL (2005) Meta-analysis of soy food and risk of prostate cancer in men. Int J Cancer 117, 667-669.
49. Hilakivi-Clarke L (2000) Estrogens, BRCA1, and breast cancer. Cancer Res 60, 4993-5001.
50. Lamartiniere CA, Cotroneo MS, Fritz WA, Wang J, Mentor-Marcel R & Elgavish A (2002) Genistein chemoprevention: Timing and mechanisms of action in murine mammary and prostate. Nutr 132, 552S-558S.
51. Cabanes A, Wang M, Olivo S, DeAssis S, Gustafsson JA, Khan G & Hilakivi-Clarke L (2004) Prepubertal estradiol and genistein exposures up-regulate BRCA1 mRNA and reduce mammary tumorigenesis. Carcinogenesis 25, 741-748.
52. Franke AA, Morimoto Y, Yeh LM & Maskarinec G (2006) Urinary isoflavones as a dietary compliance measure among premenopausal women. Asia Pac J Clin Nutr 15, 88-94.
53. Maskarinec G, Oshiro C, Morimoto Y, Hebshi S, Novomy R & Franke AA (2005) Urinary isoflavone excretion as a compliance measure in a soy intervention among young girls: A pilot study. Eur J Clin Nutr 59, 369-375.
54. Fomon SJ, Haschke F, Ziegler EE & Nelson SE (1982) Body composition of reference children from birth to age 10 years. Am J Clin Nutr 35, Suppl. 5, 1169-1175.